Beijing Sciecure Pharmaceutical Co., Ltd., established in April 2002, is a national high tech pharmaceutical enterprise
with the innovation strategy of new technology, new products, and new process.
2016 OSD Workshop and Injection Workshop approved by U.K. MHRA
2015 The production line of lyophilization passed the inspection by CFDA complying with new version GMP.
2014 The production line of ampoules passed the inspection by CFDA complying with new version GMP
2012 Sciecure was rated "Drug Quality Management Model Enterprise" by Beijing Drug Safety Engineering
construction Leading Group.
2012 Sciecure cooperated with Beijing University of Chemical Technology, became joint training base of
excellence Engineers and learning base.
2011 Sciecure was rated "Class A Taxpayer" by Beijing Tax Bureau and Beijing Local Taxation Bureau.
2011 Sciecure was rated "Beijing Scientific Research Institution" by Beijing Committee of Science and Technology.
2010 Ordinary small volume injection and freeze-dried powder injection workshop have passed GMP of SFDA.
2009 Sciecure launched the Ⅱconstruction project of the investment.
2009 Sciecure was rated "High and New Technology Enterprise" by Beijing Committee, Finance Bureau, IRS,
Local Tax Bureau.
2009 Sciecure was rated "Together Build Units" by Beijing Drug Discovery Industry Alliance.
2008 Sciecure was rated "Civilized Unit" by Beijing Shunyi Committee for the building of spiritual civiliazation.
2008 Sciecure was rated "Civilized Unit" by Beijing Shunyi Private Individual Economic Committee for the building of
spiritual civiliazation.
2007 Sciecure was rated as "Advanced Private Enterprise" by Shunyi Private Individual Economic Association.
2007 Sciecure has been restructured its equity.